Latest Orphan Drug Act Stories
Novel Product Focused On Treatment of Comorbidities of Sickle Cell Disease SOUTH PLAINFIELD, N.J., April 8, 2015 /PRNewswire/ -- Prolong Pharmaceuticals, LLC, a biopharmaceutical company
CAMBRIDGE, Mass., Feb.
COVINGTON, Ky., Feb. 16, 2015 /PRNewswire/ -- Bexion Pharmaceuticals LLC announced today that the U.S.
SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
EPI-743 in phase 2B development for Leigh syndrome MOUNTAIN VIEW, Calif., June 9, 2014 /PRNewswire/ -- Edison Pharmaceuticals today announced that the FDA has granted Orphan Drug status
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
New Kauffman Foundation paper highlights solutions to speed patients’ access to drugs with therapeutic value for more than one disease. Kansas City, MO (PRWEB)
LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Resolution Promotes Awareness of Rare Diseases Sacramento, CA (PRWEB) February 27, 2014 Today at the state Capitol, Assemblymember Kevin Mullin (D-South
EASTBOURNE, England, February 25, 2014 /PRNewswire/ -- Daval International, the emerging life sciences company focused on the development of novel treatments for serious
- A person in a secondary role, specifically the second most important character (after the protagonist).